Organogenesis Holdings (ORGO) Retained Earnings (2015 - 2026)

Organogenesis Holdings' Retained Earnings history runs 12 years deep, the most recent figure standing at -$56.2 million for Q1 2026.

• On a quarterly basis, Retained Earnings rose 4.61% year-over-year to -$56.2 million in Q1 2026; TTM through Mar 2026 was -$56.2 million, a 4.61% increase from a year earlier, with the FY2025 full-year figure at -$3.1 million, up 92.33% from the prior year.
• Retained Earnings slipped to -$56.2 million in Q1 2026 per ORGO's latest filing, from -$3.1 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$3.1 million in Q4 2025 and bottomed at -$68.3 million in Q2 2025.
• The 5-year median for Retained Earnings is -$47.8 million (2024), against an average of -$47.7 million.
• Across the five-year window, Retained Earnings sank 37.97% in 2024 and soared 92.33% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$45.3 million in 2022, then rose by 9.56% to -$41.0 million in 2023, then climbed by 2.1% to -$40.1 million in 2024, then surged by 92.33% to -$3.1 million in 2025, then tumbled by 1726.97% to -$56.2 million in 2026.
• Per Business Quant, the three latest ORGO Retained Earnings figures stand at -$56.2 million (Q1 2026), -$3.1 million (Q4 2025), and -$46.8 million (Q3 2025).